Cargando…

Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador

BACKGROUND: In contrast to the rapid increase in thyroid cancer incidence, the mortality has remained low and stable over the last decades. In Ecuador, however, thyroid cancer mortality has increased. The objective of this study is to determine possible drivers of high rates of thyroid cancer mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Solis-Pazmino, Paola, Salazar-Vega, Jorge, Lincango-Naranjo, Eddy, Garcia, Cristhian, Koupermann, Gabriela Jaramillo, Ortiz-Prado, Esteban, Ledesma, Tannya, Rojas, Tatiana, Alvarado-Mafla, Benjamin, Carcamo, Cesar, Ponce, Oscar J., Brito, Juan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791844/
https://www.ncbi.nlm.nih.gov/pubmed/33419403
http://dx.doi.org/10.1186/s12885-020-07735-y
_version_ 1783633679597174784
author Solis-Pazmino, Paola
Salazar-Vega, Jorge
Lincango-Naranjo, Eddy
Garcia, Cristhian
Koupermann, Gabriela Jaramillo
Ortiz-Prado, Esteban
Ledesma, Tannya
Rojas, Tatiana
Alvarado-Mafla, Benjamin
Carcamo, Cesar
Ponce, Oscar J.
Brito, Juan P.
author_facet Solis-Pazmino, Paola
Salazar-Vega, Jorge
Lincango-Naranjo, Eddy
Garcia, Cristhian
Koupermann, Gabriela Jaramillo
Ortiz-Prado, Esteban
Ledesma, Tannya
Rojas, Tatiana
Alvarado-Mafla, Benjamin
Carcamo, Cesar
Ponce, Oscar J.
Brito, Juan P.
author_sort Solis-Pazmino, Paola
collection PubMed
description BACKGROUND: In contrast to the rapid increase in thyroid cancer incidence, the mortality has remained low and stable over the last decades. In Ecuador, however, thyroid cancer mortality has increased. The objective of this study is to determine possible drivers of high rates of thyroid cancer mortality, through a cross-sectional analysis of all patients attending a thyroid cancer referral center in Ecuador. METHODS: From June 2014 to December 2017, a cross-sectional study was conducted at the Hospital de Especialidades Eugenio Espejo, a regional reference public hospital for endocrine neoplasia in adults in Quito, Ecuador. We identified the mechanism of detection, histopathology and treatment modalities from a patient interview and review of clinical records. RESULTS: Among 452 patients, 74.8% were young adults and 94.2% (426) were female. 13.7% had a family history of thyroid cancer, and patients’ median tumor size was 2 cm. The incidental finding was 54.2% whereas 45.8% was non-incidental. Thyroid cancer histology reported that 93.3% had papillary thyroid cancer (PTC), 2.7% follicular, 1.5% Hurtle cells, 1.6% medullary, 0.7% poor differentiated, and 0.2% anaplastic carcinoma. The mean MACIS (metastasis, age, completeness, invasion, and size) score was 4.95 (CI 4.15–5.95) with 76.2% of the thyroid cancer patients having MACIS score less than or equal to 6. The very low and low risk of recurrence was 18.1% (79) and 62% (271) respectively. An analysis of 319 patients with non-metastatic thyroid cancer showed that 10.7% (34) of patients had surgical complications. Moreover, around 62.5% (80 from 128 patients with thyroglobulin laboratory results) of TC patients had a stimulated-thyroglobulin value equal or higher than 2 ng/ml. Overall, a poor surgical outcome was present in 35.1% (112) patients. Out of 436 patients with differentiated thyroid carcinoma, 86% (375) received radioactive iodine. CONCLUSION: Thyroid cancer histological characteristics and method of diagnosis are like those described in other reports without any evidence of the high frequency of aggressive thyroid cancer histology. However, we observed evidence of overtreatment and poor surgical outcomes that demand additional studies to understand their association with thyroid cancer mortality in Ecuador.
format Online
Article
Text
id pubmed-7791844
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77918442021-01-11 Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador Solis-Pazmino, Paola Salazar-Vega, Jorge Lincango-Naranjo, Eddy Garcia, Cristhian Koupermann, Gabriela Jaramillo Ortiz-Prado, Esteban Ledesma, Tannya Rojas, Tatiana Alvarado-Mafla, Benjamin Carcamo, Cesar Ponce, Oscar J. Brito, Juan P. BMC Cancer Research Article BACKGROUND: In contrast to the rapid increase in thyroid cancer incidence, the mortality has remained low and stable over the last decades. In Ecuador, however, thyroid cancer mortality has increased. The objective of this study is to determine possible drivers of high rates of thyroid cancer mortality, through a cross-sectional analysis of all patients attending a thyroid cancer referral center in Ecuador. METHODS: From June 2014 to December 2017, a cross-sectional study was conducted at the Hospital de Especialidades Eugenio Espejo, a regional reference public hospital for endocrine neoplasia in adults in Quito, Ecuador. We identified the mechanism of detection, histopathology and treatment modalities from a patient interview and review of clinical records. RESULTS: Among 452 patients, 74.8% were young adults and 94.2% (426) were female. 13.7% had a family history of thyroid cancer, and patients’ median tumor size was 2 cm. The incidental finding was 54.2% whereas 45.8% was non-incidental. Thyroid cancer histology reported that 93.3% had papillary thyroid cancer (PTC), 2.7% follicular, 1.5% Hurtle cells, 1.6% medullary, 0.7% poor differentiated, and 0.2% anaplastic carcinoma. The mean MACIS (metastasis, age, completeness, invasion, and size) score was 4.95 (CI 4.15–5.95) with 76.2% of the thyroid cancer patients having MACIS score less than or equal to 6. The very low and low risk of recurrence was 18.1% (79) and 62% (271) respectively. An analysis of 319 patients with non-metastatic thyroid cancer showed that 10.7% (34) of patients had surgical complications. Moreover, around 62.5% (80 from 128 patients with thyroglobulin laboratory results) of TC patients had a stimulated-thyroglobulin value equal or higher than 2 ng/ml. Overall, a poor surgical outcome was present in 35.1% (112) patients. Out of 436 patients with differentiated thyroid carcinoma, 86% (375) received radioactive iodine. CONCLUSION: Thyroid cancer histological characteristics and method of diagnosis are like those described in other reports without any evidence of the high frequency of aggressive thyroid cancer histology. However, we observed evidence of overtreatment and poor surgical outcomes that demand additional studies to understand their association with thyroid cancer mortality in Ecuador. BioMed Central 2021-01-08 /pmc/articles/PMC7791844/ /pubmed/33419403 http://dx.doi.org/10.1186/s12885-020-07735-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Solis-Pazmino, Paola
Salazar-Vega, Jorge
Lincango-Naranjo, Eddy
Garcia, Cristhian
Koupermann, Gabriela Jaramillo
Ortiz-Prado, Esteban
Ledesma, Tannya
Rojas, Tatiana
Alvarado-Mafla, Benjamin
Carcamo, Cesar
Ponce, Oscar J.
Brito, Juan P.
Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador
title Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador
title_full Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador
title_fullStr Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador
title_full_unstemmed Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador
title_short Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador
title_sort thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in ecuador
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791844/
https://www.ncbi.nlm.nih.gov/pubmed/33419403
http://dx.doi.org/10.1186/s12885-020-07735-y
work_keys_str_mv AT solispazminopaola thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador
AT salazarvegajorge thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador
AT lincangonaranjoeddy thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador
AT garciacristhian thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador
AT koupermanngabrielajaramillo thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador
AT ortizpradoesteban thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador
AT ledesmatannya thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador
AT rojastatiana thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador
AT alvaradomaflabenjamin thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador
AT carcamocesar thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador
AT ponceoscarj thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador
AT britojuanp thyroidcanceroverdiagnosisandovertreatmentacrosssectionalstudyatathyroidcancerreferralcenterinecuador